移為通信(300590.SZ):一季度兩輪車銷售收入下降主要受兩輪車客户融資受阻,目前在消化庫存等的影響
格隆匯5月5日丨有投資者在投資者互動平台向移為通信(300590.SZ)提問,“季報公佈主營下降主要受兩輪車影響,二季度是否有好轉?主營其他領域的增長能否抵消兩輪影響?”
移為通信回覆稱,一季度兩輪車銷售收入下降主要受兩輪車客户融資受阻,目前在消化庫存等的影響。但公司其他業務板塊較為穩定,資產管理類和動物溯源產品都有較好的增長。公司作為業界領先的無線物聯網設備和解決方案提供商,未來將持續推動新產品的研發,並充分利用全球化銷售渠道優勢,降本增效等多重手段努力提升業績。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.